The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2023 | Challenges in understanding the genomic landscape of Hodgkin lymphoma
Sven Borchmann, MD, University of Cologne, Cologne, Germany, discusses the challenges in understanding the genomic landscape of Hodgkin lymphoma (HL), particularly compared to solid tumors. Dr Borchmann highlights the benefits of using circulating tumor DNA (ctDNA) to study HL genomics. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
